Synchrony Financial $SYF Shares Bought by NEOS Investment Management LLC
NEOS Investment Management LLC recently increased its stake in Synchrony Financial (NYSE:SYF) by 42% in Q3, now owning 53,599 shares worth approximately $3.81 million. Synchrony Financial exceeded Q3 EPS expectations, reporting $2.18 against an estimated $2.02, and provided strong FY2026 EPS guidance of $9.10–$9.50. Despite some insider selling, analysts maintain a "Moderate Buy" rating with an average target price of $87.11, and the company offers a quarterly dividend of $0.30, yielding 1.7%.
Regional Management Corp: Quiet Stock, Big Credit Risk Question for 2025
Regional Management Corp (NYSE: RM) is currently a high-sensitivity play on US subprime loan performance and Federal Reserve policy. The small-cap lender faces potential volatility tied to consumer credit stress and labor market strength, offering a high earnings yield for investors willing to underwrite non-prime household risk.
Synchrony Financial EVP, CEO--digital sells $2.49 million in stock
Bart Schaller, EVP, CEO--Digital at Synchrony Financial, sold 35,300 shares of common stock for $2.49 million. The transaction occurred while SYF trades at a P/E ratio of 7.77 and a market cap of $25.1 billion, with its stock considered fairly valued. This follows recent Q4 2025 earnings where EPS met expectations but revenue fell short, and an upgrade in stock rating by Baird.
Synchrony Financial EVP, CEO--digital sells $2.49 million in stock By Investing.com
Bart Schaller, EVP, CEO--Digital at Synchrony Financial, sold 35,300 shares of common stock for $2.49 million on February 17, 2026, under a pre-arranged trading plan. Despite the sale, which reduced his direct holdings to 42,300 shares, Synchrony Financial is considered fairly valued by InvestingPro analysis. This insider transaction follows the company's recent Q4 2025 earnings report, which met EPS expectations but missed revenue forecasts, alongside strategic partnerships and an analyst upgrade to Outperform.
Weave partners with Synchrony to integrate CareCredit financing solution
Weave has announced a partnership with Synchrony to integrate CareCredit's patient financing solution into its platform for healthcare businesses. This integration aims to streamline operations by allowing healthcare providers to view CareCredit status directly within Weave's system, helping to reduce treatment deferrals due to cost concerns. The partnership also enables practices to initiate CareCredit payments in-office or via text-to-pay, with patients able to apply for credit within the Weave platform.
Weave Communications, Inc (NYSE: WEAV) recently announced a key strategic partnership with Synchrony®, a leading provider of patient financing services in the industry.
Weave Communications, Inc (NYSE: WEAV) has announced a strategic partnership with Synchrony®, integrating Synchrony's CareCredit patient financing solution into Weave's platform. This collaboration aims to offer healthcare providers and their patients more flexible payment options. The initiative seeks to enhance the patient experience and foster growth for healthcare practices.
Insider Sell: Carol Juel Sells 44,411 Shares of Synchrony Financ
Carol Juel, an insider at Synchrony Financial (SYF), sold 44,411 shares of the company on February 17, 2026, reducing her holdings to 58,773 shares. This transaction follows a pattern of insider selling at SYF, with 25 insider sells and no insider buys over the past year. Synchrony Financial's stock is currently trading at $70.6, considered modestly overvalued with a price-to-GF-Value ratio of 1.22, despite its low P/E ratio compared to the industry and historical median.
Weave Announces Fourth Quarter and Full Year 2025 Financial Results
Weave Communications, Inc. announced strong financial results for the fourth quarter and full year ended December 31, 2025, with revenue up 17.0% year over year for both periods, reaching $63.4 million and $239.0 million, respectively. The company also reported record gross margins and operating income, along with significant growth in net cash provided by operating activities and free cash flow. Weave provided a positive outlook for the first quarter and full year 2026, anticipating continued growth in revenue and non-GAAP income from operations.
Synchrony Financial’s CareCredit Push Into Dental Workflows Meets Depressed Valuation
Synchrony Financial is expanding its CareCredit partnership with Planet DDS, integrating its financing into orthodontic and dental practice management platforms. This move is expected to streamline patient financing for dental treatments, potentially impacting Synchrony’s healthcare receivables and market reach. Despite the positive partnership, the company faces a depressed valuation, with its stock trading below analyst targets and Simply Wall St's fair value estimate, and analysts forecasting a decline in earnings over the next three years.
Weave partners with Synchrony to integrate CareCredit financing solution By Investing.com
Weave (NYSE:WEAV) has partnered with Synchrony (NYSE:SYF) to integrate CareCredit's patient financing solution into its platform for small and medium-sized healthcare businesses. This collaboration aims to streamline operations by allowing healthcare providers to view patient CareCredit status and available funds directly within Weave's system, thereby reducing barriers to treatment due to cost concerns. The integration enables in-office or text-to-pay CareCredit payments and allows patients to apply for credit via the Weave platform, with 43% of Weave payment customers indicating they would exclusively use Weave's payment services with CareCredit.
Weave partners with Synchrony to integrate CareCredit financing solution
Weave and Synchrony have partnered to integrate CareCredit's patient financing solution into Weave's platform for small and medium-sized healthcare businesses. This integration aims to simplify healthcare operations by allowing providers to manage patient financing within Weave's system, reducing friction and cost concerns for patients. The collaboration enables in-office or text-to-pay initiated CareCredit payments and direct credit applications, improving efficiency and accessibility for healthcare treatments.
ACI Worldwide Executive Joins MIT Fintech Conference Panel
Philip Bruno, ACI Worldwide's Chief Strategy and Growth Officer, will participate in the MIT Fintech Conference to discuss how AI agents and payment infrastructures are transforming commercial decision-making. The conference will cover emerging trends like zero-click purchasing and interoperable wallet protocols while emphasizing the necessity of trust and security in AI-driven financial systems.
Synchrony Launches First-of-Its-Kind Social App to Support Neurodivergent Adults in Building Friendship, Community and Independence
Synchrony has launched a new social connection platform designed to help neurodivergent adults form friendships, build confidence, and find belonging. The app focuses on interest-based matching, a verified and moderated community, and offers an optional AI-supported coaching tool named Jesse to help users navigate social interactions. This initiative aims to address the social isolation neurodivergent individuals often experience after leaving structured school environments, providing a safe and supportive space.
Weave Announces Strategic CareCredit Integration Partnership with Patient Financing Leader Synchrony®
Weave (NYSE: WEAV) has partnered with Synchrony (NYSE: SYF) to integrate its CareCredit patient financing solution into Weave's platform. This integration aims to streamline operations for healthcare practices and make patient financing more accessible and transparent. It will allow staff to view CareCredit status directly within Weave, helping patients more easily opt into necessary treatments.
Weave Announces Strategic CareCredit Integration Partnership with Patient Financing Leader Synchrony
Weave, a software platform for healthcare businesses, has partnered with Synchrony's CareCredit to integrate patient financing directly into its systems. This integration aims to improve operational efficiency for practices and provide patients with clearer, easier access to financing options, leading to earlier treatment acceptance. The new feature will allow staff to view patient CareCredit status and funds within Weave, streamline payments, and offer mobile-first application options.
Synchrony, Planet DDS expand financing partnership across dental platforms By Investing.com
Synchrony (NYSE:SYF) has expanded its partnership with Planet DDS, integrating its CareCredit financing solution into Planet DDS's dental practice management platforms, Denticon and Cloud 9. This collaboration aims to streamline financial workflows for dental and orthodontic practices, providing a preferred patient financing option. The expanded partnership extends CareCredit's reach to approximately 17,500 dental and orthodontic practices, potentially impacting millions of patients nationwide by simplifying access to treatment financing.
Synchrony Financial’s CareCredit Push Into Dental Workflows Meets Depressed Valuation
Synchrony Financial (NYSE:SYF) is expanding its CareCredit partnership with Planet DDS, integrating its financing into orthodontic and dental practice management platforms. This strategic move aims to streamline patient financing for higher-ticket treatments and embed CareCredit deeper into healthcare workflows, potentially influencing receivables and customer reach. Despite this expansion, Synchrony Financial's stock is currently trading significantly below analyst targets and Simply Wall St's fair value estimate, with forecasted earnings expected to decline over the next three years.
Weave Communications, Inc (NYSE: WEAV) recently announced a key strategic partnership with Synchrony®, a leading provider of patient financing services in the industry.
Weave Communications, Inc (NYSE: WEAV) has announced a strategic partnership with Synchrony®, integrating Synchrony's CareCredit patient financing solution into Weave's platform. This collaboration aims to offer more flexible and convenient payment options for healthcare providers and their patients who use Weave services. The partnership is expected to optimize the patient experience and contribute to practice growth.
Planet DDS Expands Access to CareCredit Financing
Synchrony has announced an expanded strategic partnership with Planet DDS to streamline patient financing in orthodontic and dental practices. This collaboration integrates CareCredit into Planet DDS's Cloud 9 orthodontic practice management platform, making patient financing easier and more accessible. CareCredit will become the preferred patient financing solution across all Planet DDS platforms, including Denticon and Cloud 9.
Aberdeen Group plc Decreases Stake in Synchrony Financial $SYF
Aberdeen Group plc reduced its stake in Synchrony Financial by 17.5%, selling 66,673 shares to own 315,127 shares worth $23.1 million. This comes amidst other institutional investor adjustments and significant insider selling by director Arthur W. Coviello, Jr. and insider Curtis Howse, who both sold large blocks of shares. Synchrony Financial reported better-than-expected Q4 EPS and provided positive FY2026 guidance, while also paying a quarterly dividend.
Synchrony and Planet DDS Expand Strategic Partnership to Integrate CareCredit Across Leading Dental Practice Management Platforms
Synchrony and Planet DDS have expanded their strategic partnership, making CareCredit the preferred patient financing solution across all Planet DDS platforms, including Denticon and Cloud 9. This integration will embed CareCredit financing directly into the workflows of thousands of dental and orthodontic practices, simplifying patient financing and enhancing operational efficiency. It marks Synchrony's first integration into an orthodontic-specific practice management system, bringing financial solutions to over 2,500 Cloud 9 orthodontic practices and 15,000+ Denticon dental practices.
Millions of dental and braces patients get financing in CareCredit tie-up
Synchrony (NYSE: SYF) and Planet DDS have expanded their partnership to integrate CareCredit, Synchrony's patient financing solution, across Planet DDS's platforms, including Denticon for dental practices and Cloud 9 for orthodontic practices. This collaboration will make CareCredit available to over 15,000 Denticon practices and 2,500 Cloud 9 orthodontic practices, streamlining financing applications and payments for millions of patients. The integration marks CareCredit's first entry into an orthodontic-specific practice management system, aiming to improve operational efficiency for practices and ease access to care for patients.
Synchrony and Planet DDS Expand Strategic Partnership to Integrate CareCredit Across Leading Dental Practice Management Platforms – Company Announcement - FT.com
Synchrony and Planet DDS have expanded their strategic partnership, making CareCredit the preferred patient financing solution across all Planet DDS platforms, including Denticon and Cloud 9. This integration will allow dental and orthodontic practices to embed CareCredit financing directly into their workflows, simplifying financial conversations and enhancing patient access to care. The partnership aims to improve operational efficiency for practices and provide patients with easier access to flexible financing options, building on an existing relationship from 2020.
Better Credit Results Offsetting Synchrony's Poor Loan Growth
Synchrony Financial, which partners with retailers and medical providers for financing and credit cards, is reportedly experiencing improved credit results that are compensating for slower loan growth. The company's CareCredit cards and installment loans have performed consistently well, though its private-label and co-branded cards are more susceptible to downturns in retail sales. This analysis points to a mixed performance for Synchrony, with strong credit management helping to mitigate weaknesses in loan expansion.
Synchrony Financial: Wall Street Turns Cautious – Opportunity or Value Trap?
Synchrony Financial's latest earnings show solid revenue growth but also rising credit losses, making its stock a high-beta play on US consumer health. Analysts are cautious, with some lowering price targets despite the company's strong capital and share repurchases, suggesting it's a volatile stock best suited for investors who actively monitor macro data and are comfortable with potential drawdowns. The article advises that Synchrony could be an opportunity if the US consumer remains resilient but poses a risk if a deeper downturn occurs.
Survey finds drivers underestimate yearly car costs by $4,565 on average
A new Synchrony survey reveals that drivers significantly underestimate their annual car ownership costs by an average of $4,565, expecting to pay $2,738 but actually spending $7,303 (excluding loan/lease payments). Younger generations, particularly Millennials and Gen Z, face even higher annual expenses, sometimes exceeding $10,000. This disparity is leading to shifts in consumer behavior, such as keeping cars longer and a decline in multicar households, highlighting the need for flexible financing solutions like the Synchrony Car Care Credit Card to manage these rising costs.
Synchrony: think your car costs under $3K? Try $7,303 a year
A new Synchrony survey reveals that U.S. drivers drastically underestimate the annual cost of car ownership, spending an average of $7,303—nearly 167% more than their estimated $2,738. Gas and insurance are the primary expenses, while younger generations like Millennials and Gen Z face even higher costs, averaging around $10,000 annually. Synchrony highlights its Car Care Credit Card as a financing solution to help mitigate these unexpected financial burdens.
Drivers Underestimate the Annual Cost of Car Ownership by More Than $4,500, New Synchrony Survey Finds
A new survey by Synchrony reveals that drivers significantly underestimate the annual cost of car ownership, paying nearly 167% more than expected, a discrepancy of over $4,500. This misinformation puts a strain on household budgets and shifts consumer behavior, with many opting to keep their vehicles longer. The survey highlights that insurance is the biggest contributor to these rising costs, followed by maintenance and repairs, and indicates that younger generations (Gen Z and Millennials) are leading spenders across various car-related expenses.
Assessing American Express (AXP) Valuation After Recent Share Price Weakness
American Express (AXP) has experienced recent share price weakness, with a 30-day decline of 7.5%, despite strong longer-term returns. While one valuation narrative suggests AXP is 9.5% overvalued at $337.50 with a fair value of $308.19 due to growth and profitability assumptions, another discounted cash flow model indicates undervaluation with a fair value of $383.56. Investors are encouraged to consider both perspectives and assess their own growth and risk tolerances.
Todd Asset Management LLC Sells 134,219 Shares of Synchrony Financial $SYF
Todd Asset Management LLC significantly reduced its stake in Synchrony Financial ($SYF) by selling 134,219 shares in the third quarter, decreasing its holdings by 28.0%. Despite this, institutional investors and hedge funds still own 96.48% of the company's stock, which recently announced a quarterly dividend of $0.30 per share. Analysts have a "Moderate Buy" rating on SYF with a consensus target price of $87.11, following recent upgrades and downgrades, while company insiders have also sold shares.
A Look At Synchrony Financial’s (SYF) Valuation After Recent Share Price Volatility
Synchrony Financial (SYF) is experiencing share price volatility, with recent declines despite strong long-term returns. The stock is currently trading at $71.38, showing a significant discount to its intrinsic value estimated around $145 per share by DCF/Excess Return analysis, and also to analyst targets. The valuation narrative suggests it's 32% undervalued, but this could change with rising consumer credit losses or new regulations.
International Flavors Reshapes Portfolio With Food Ingredients Sale And Focused Core
International Flavors & Fragrances (IFF) is initiating a formal sale of its Food Ingredients business and other non-core assets to focus on higher-value segments like Taste, Scent, and Health & Biosciences. This strategic divestiture aims to improve capital allocation, reduce debt, and allow for share repurchases, especially after a significant net loss in 2025. The success of this portfolio reshaping will depend on execution, the terms of sales, and the performance of the remaining core segments.
Shell Asset Management Co. Sells 64,558 Shares of Synchrony Financial $SYF
Shell Asset Management Co. significantly reduced its stake in Synchrony Financial (NYSE: SYF) by 68% in the third quarter, selling 64,558 shares and retaining 30,342 shares valued at $2.156 million. Despite this, Synchrony Financial reported strong quarterly earnings, beating EPS estimates, and announced a quarterly dividend. Insider selling also occurred, with executives offloading 88,556 shares over the last quarter.
Cibc World Market Inc. Acquires 36,852 Shares of Synchrony Financial $SYF
Cibc World Market Inc. increased its stake in Synchrony Financial by 83.5% in the third quarter, acquiring 36,852 additional shares, bringing its total to 80,990 shares valued at approximately $5.754 million. Synchrony Financial reported strong Q3 earnings per share of $2.18, exceeding analyst expectations, and announced a quarterly dividend of $0.30. Analysts maintain a "Moderate Buy" rating for SYF, with a consensus price target of around $87.11.
Synchrony Announces Quarterly Common Stock Dividend of $0.25 Per
Synchrony Financial announced a quarterly cash dividend of $0.25 per share for common stock, representing a 9% increase, payable on August 10, 2023. The company also declared a quarterly cash dividend on its Series A Preferred Stock, amounting to approximately $14.06 per share, payable on August 14, 2023. Synchrony is a consumer financial services company offering digitally-enabled product suites across various industries.
Short Interest in Synchrony Financial (NYSE:SYF) Declines By 27.1%
Synchrony Financial (NYSE:SYF) experienced a significant 27.1% decrease in short interest in January, reaching 13,143,709 shares as of January 30th. Insiders have been net sellers, offloading over 88,000 shares worth $6.42 million in the last three months, though institutional investors still hold 96.48% of the stock. The company beat Q4 earnings estimates with $2.18 EPS, set strong FY2026 guidance, and holds a consensus "Moderate Buy" rating from analysts with an average target price of $87.11.
Rhumbline Advisers Sells 30,730 Shares of Synchrony Financial $SYF
Rhumbline Advisers reduced its stake in Synchrony Financial (NYSE:SYF) by 4.0% in the third quarter, selling 30,730 shares and now owning 729,370 shares valued at $51.82 million. Other institutional investors also adjusted their holdings, with Bank of America Corp DE significantly increasing its stake, while insiders like Jonathan S. Mothner and Arthur W. Coviello, Jr. sold shares. Synchrony Financial reported strong earnings, beating analyst estimates, and announced a quarterly dividend of $0.30 per share.
Baird upgrades Synchrony Financial stock rating to Outperform on valuation By Investing.com
Baird has upgraded Synchrony Financial (NYSE:SYF) from Neutral to Outperform, setting an $83.00 price target, citing recent weakness in consumer finance stocks as a good entry point. The firm highlighted Synchrony's strong financial health, risk-sharing agreements, and robust capital position, enabling aggressive capital returns. Despite a recent revenue shortfall, Baird believes the stock is undervalued, trading at 1.9 times tangible book value and 7.6 times 2026 estimated earnings, and dismisses concerns about potential interest rate caps.
Synchrony upgraded to Outperform from Neutral at Baird
Baird upgraded Synchrony (SYF) to Outperform from Neutral, maintaining an $83 price target. Analyst David George noted that the risk/reward for the bank has improved after recent share weakness. He identified consumer finance as offering the best risk/reward and sees the current "de-risking weakness" as a good entry point for the stock.
Is Synchrony Financial (SYF) Offering An Opportunity After Recent Share Price Pullback?
Synchrony Financial (SYF) has experienced recent share price declines, presenting a potential opportunity for investors. Analysis using the Excess Returns model and Price vs. Earnings suggests that the stock is currently undervalued by approximately 54.0% and is trading below its company-specific Fair Ratio of 15.8x. The article also presents bull and bear case Narratives with varying fair value estimates, encouraging investors to consider their own views on future growth, margins, and risk.
Synchrony Financial (NYSE:SYF) Rating Increased to Outperform at Robert W. Baird
Robert W. Baird has upgraded Synchrony Financial (NYSE:SYF) from "neutral" to "outperform" with an $83 price target, signaling a 16.7% potential upside. The upgrade follows Synchrony exceeding Q1 EPS estimates and issuing strong FY2026 guidance, surpassing analyst forecasts. The company currently holds a consensus "Moderate Buy" rating with an average analyst price target of $87.11.
Forecasting The Future: 15 Analyst Projections For Synchrony Financial
Over the past three months, 15 analysts have provided varied projections for Synchrony Financial (NYSE: SYF), with views ranging from bullish to indifferent. The average 12-month price target for SYF has increased by 3.2% to $91.4, with estimates spanning $82.00 to $101.00. While the company demonstrates a strong market position and efficient cost management with a 19.25% net margin, it faces challenges with a negative revenue trend and lower than average ROE and ROA compared to industry peers.
Baird Upgrades Synchrony Financial to Outperform From Neutral, Price Target is $83
Baird has upgraded Synchrony Financial (SYF) to "Outperform" from "Neutral," setting a new price target of $83. This upgrade reflects a more positive outlook on the consumer lending company by the analyst firm. The article also provides recent news and analyst actions concerning Synchrony Financial, including other ratings and price target adjustments.
Baird upgrades Synchrony Financial stock rating to Outperform on valuation
Baird has upgraded Synchrony Financial (NYSE:SYF) from Neutral to Outperform, setting a price target of $83.00, citing attractive valuation after recent weakness in consumer finance stocks. The firm highlighted Synchrony's solid pre-provision net revenue trends, favorable credit metrics, strong capital position, and aggressive capital returns, with the stock trading at modest valuations despite strong financial health. Baird also downplayed concerns about potential interest rate caps, viewing the recent sell-off as a buying opportunity for the company, which also reported aligned EPS but missed revenue forecasts for Q4 2025.
COF vs. SYF: Which Credit Card Lender Offers More Upside?
This article compares Capital One (COF) and Synchrony Financial (SYF), two major credit card lenders, to determine which offers more long-term growth potential for investors. It delves into their business models, strategic acquisitions, financial performance, and market valuations. While both face challenges from potential interest rate caps, Capital One appears to have a slight edge due to its diversified model, recent acquisitions like Discover, and stronger anticipated revenue and earnings growth.
Baird upgrades Synchrony Financial stock rating to Outperform on valuation By Investing.com
Baird has upgraded Synchrony Financial (NYSE:SYF) to Outperform with an $83 price target, citing recent weakness in consumer finance stocks as a buying opportunity. The firm highlights Synchrony's strong financial health, risk-sharing agreements, and aggressive capital returns, noting the stock trades at attractive valuations despite solid credit trends. This upgrade follows Synchrony's Q4 2025 earnings, which met EPS expectations but missed revenue forecasts.
Assetmark Inc. Purchases 1,416,909 Shares of Synchrony Financial $SYF
Assetmark Inc. significantly increased its stake in Synchrony Financial (SYF) by 48.3% in Q3, acquiring an additional 1.4 million shares and now owning 1.21% of the company worth $309 million. Synchrony Financial exceeded quarterly EPS expectations and provided strong FY2026 guidance, though analyst sentiments are mixed regarding the near-term outlook. Institutional ownership is high at 96.5%, and the company recently declared a quarterly dividend of $0.30 per share.
Synchrony Financial Breaks Below 200-Day Moving Average - Notable for SYF
Synchrony Financial (SYF) shares recently fell below their 200-day moving average of $71.56, trading as low as $69.97. This movement represents a 2.5% decrease for the day and is notable for investors tracking technical indicators. The stock's 52-week range spans from $40.545 to $88.77.
COF vs. SYF: Which Credit Card Lender Offers More Upside?
This article compares Capital One (COF) and Synchrony Financial (SYF), two major players in consumer lending, to determine which offers more upside. Capital One, with its diversified approach and strategic acquisitions like Discover, aims for broader market dominance, while Synchrony Financial focuses on niche private-label and co-branded cards through strong retailer partnerships. While both face challenges from potential credit card interest rate caps, Capital One appears better positioned for long-term growth due to its larger scale and acquisition strategy, despite Synchrony's strong niche profitability.
What is Zacks Research's Estimate for SYF FY2028 Earnings?
Zacks Research analysts have significantly raised their FY2028 EPS estimate for Synchrony Financial (NYSE: SYF) to $11.11, notably higher than the current consensus of $7.67, indicating a bullish long-term outlook. This update comes as Synchrony reported strong Q4 earnings, beating expectations with $2.18 EPS and maintaining its FY2026 guidance. Despite the positive financial news and a new $1.0 billion share buyback authorization, recent insider selling activity tempers the capital-return signal.
